Recent Insights » Therapeutic & Scientific Innovations » Quiz: Can You Mitigate Human Error in Your Trial?
Other content in this Stream
How Calibrated Are Your Trial-Measurement Tools?
Lack of Training Compromises Trial Results
Mind Map: Building a Framework for Measurement Reliability
Placebo Response in Clinical Trials: Approaches to Mitigation
Industry trends show that a major contributor to trial failure is the increased rate of placebo response.Watch this webinar to learn how to increase the chances of trial success in an uncertain world.
Addressing Suggestibility as a Psychological Phenomenon in Clinical Trials
It is important to understand patient perspectives and to anticipate how subjects in research studies may be impacted by the presence of digital tools, devices, and mobile health applications
How Optimized Training Can Lead to a Positive Clinical Trial
Clinical Researcher: Myths and Realities of Placebo Response - A 21st Century Prescription
Rates of placebo response across multiple therapeutic areas are now historically high. This article addresses 3 commonly shared ideas that researchers have about placebo response.
Improving Subject Selection and Endpoint Management in Alzheimer's Trials
Podcast: Important Trends in CNS Clinical Trials in 2019 with guest Christoph Correll, MD
Podcast: Exciting Developments in Psychopharmacology with guest Andrew Cutler, MD
Podcast: The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH
4 Recurring Risks to Consider in Early Phase CNS Research
Early phase CNS research is plagued by a higher than average failure rate and complicated by a lack of discreet endpoints. So how can sponsors ameliorate their chances of success from the start?
Are Scientists Closing in on Treatments for Schizophrenia's Most Elusive Symptoms?
Researchers, buoyed by a spike in promising clinical trials and tools, believe they may be close to unraveling new ways to treat some of the most insidious yet elusive effects of schizophrenia
CNS Science Has Outpaced Tool Development; It’s Time to Catch Up
For the first time in decades, we’re developing CNS drugs with new mechanisms of action. Unfortunately, our measurement tools are stuck in the past.
Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia
The aim of this paper is to discuss how the measurement gap between research and clinical care in schizophrenia can be closed.
The Digital Pill
We are experiencing a revolution in healthcare, with powerful medicine and innovative technology coming together to transform the way we treat patients and manage diseases.
Q&A with Dr. Sofija Jovic
Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG...
Podcast: The Most Pressing Challenges and Opportunities in Pain Research with guest Nathaniel Katz, MD, MS
Precision Medicine: A Glossary of Terms